Schmidt H, Weber P, Merola S,
Ballantyne GH. Laparoscopic gastric bypass. Society of American Gastrointestinal
Endoscopic Surgeons (SAGES). Storz Endoscopy Booth; St. Louis, Missouri, April 20th,
2001
Weber P, Merola S, Wasielewski A, Fan
P, Davies R, Ballantyne GH, Schmidt H. Laparoscopic Gastric Bypass in Super-Obese
Patients. 9th International Congress of the International Association of
European Endoscopic Surgeons. Maastricht, Netherland. June 13-16, 2001.
Oliak D,
Schmidt H, Weber P, Wasielewski A, Fan P, Ballantyne GH.. The learning curve
for laparoscopic roux-en-Y gastric bypass. 8th World Congress, SAGES (Society of
Gastrointestinal Endoscopic Surgeons), New York, New York, March n16th, 2002.
Oliak D, Schmidt
H, Fan P, Ballantyne GH. Is laparoscopic gastric bypass safe for patients with BMI greater
than 60? American Society for Bariatric Surgeons. 2002.
Oliak D, Schmidt
H, Wasielewski A, Ballantyne GH. Laparoscopic gastric bypass in a patient with a BMI of
75. EAES (European Association of Endoscopic Surgerons), Lisbon, Portugal, June 4th,
2002. (video presentation).
Oliak D, Schmidt
H, Wasielewski A, Davies RJ, Ballantyne GH. Laparoscopic gastric bypass for older
patients. SLS (Society of Laparoendoscopic Surgeons), New Orleans, September,
2002
Svahn
J, Schmidt H, Haag B, Trivedi A, Wasielewski A, BALLANTYNE GH. Transabdominal access for
ERCP following laparoscopic gastric bypass. European Association of Endoscopic Surgeons.
Glosgow, United Kingdom. June 18th, 2003.
BALLANTYNE
GH. Outcomes for laparoscopic gastric bypass. Peruvian Society of Surgeons. Lima, Peru.
November 21, 2003.
BALLANTYNE GH. Predictors of Hospital Length of Stay Following Open and
Laparoscopic Gastric Bypass for Morbid Obesity. Surgical Biology Club III.
American College of Surgeons. Chicago, Illinois. October 19th, 2003.
Ewing DR, Capella
RF, Capella JF, Davis D, Schmidt J, Wasielewski A, BALLANTYNE GH. Factors that
impact operative times for laparoscopic and open gastric bypass. Society of
Gastrointestinal Endoscopic Surgeons (SAGES). Denver, Colorado. April 1,
2004. (Poster).
Chau Y, BALLANTYNE
GH, Trivedi A, Wasielewski A, BALLANTYNE GH, Schmidt J. Factors that impact
weight loss following laparoscopic adjustable gastric banding. The American
Society of Bariatric Surgery (ASBS). San Diego, CA. June, 2004.
BALLANTYNE GH.
Achieving excellent long term outcomes following bariatric surgery. 2nd
National Conference on Adding, Updating and Expanding Bariatric Surgery Service.
Washington, D.C. July 24th, 2004.
O’Brien
P, Nyugen M, BALLANTYNE GH. Laparoscopic
gastric bypass or laparoscopic adjustable gastric banding for morbid obesity.
American
College of Surgeons.
Apllied Medical Booth. New Orleans, LA. October 12th, 2004.
Iannace
VA; Capella RF, BALLANTYNE GH, Capella JF. Tubular
Banded Gastric Bypass for the Treatment of Extreme Obesity (Triple Obesity).
The American Society of Bariatric Surgery, Orlando, FL, June 2005. (Poster).
Iannace
VA, Capella RF, BALLANTYNE GH, Capella JF, MD
Erosions and Migrations of Restrictive Bands Following Bariatric Surgery. The
American Society of Bariatric Surgery, Orlando,
FL, June 2005. (Poster)
Laker S,
Farkas D, Iannace V, Wasielewski A, Schmidt H, Trivedi A, BALLANTYNE GH
Laparoscopic Roux-En-Y Gastric Bypass (LRYGB) Resolves Insulin Resistance (IR):
Incretin or Adipocytokine Action? The Society for American Gastrointestinal
Endoscopic Surgeons (SAGES), Hollywood, FL, April, 2005
Farkas D,
Laker S, Iannace V, Wasielewski A, Schmidt H, Trivedi A, BALLANTYNE GH. How Much
of the Weight Loss After Laparoscopic Gastric Bypass is Fat? The Society for American Gastrointestinal Endoscopic
Surgeons (SAGES),Hollywood, FL,
April, 2005.
Farkas D, Laker S, Iannace V, Wasielewski A, Schmidt H, Trivedi A,
BALLANTYNE GH. Patients 12 Months After Laparoscopic Gastric Bypass have Body
Compositions Similar to Controls. The Society for American Gastrointestinal
Endoscopic Surgeons ( SAGES),
Hollywood, FL, April, 2005.
Farkas D, Laker S, Iannace V, Wasielewski A, BALLANTYNE GH.Insulin Resistance Improves Within Three Months After Both Laparoscopic
Gastric Bypass and Lap-Band. The European Association of Endoscopic Surgeons
(EAES),
Venice, Italy, June, 2005.
BALLANTYNE GH. Gut Hormones & Appetite. Advanced Course in Morbid
Obesity Surgery. The European
Institute of Tele-Surgery. IRCAD-EITS. University
of Strasbourg.
Strasbourg, Alsace, France. October 1st, 2005.
BALLANTYNE GH. The Future of
Bariatric Surgery. Advanced Course in Morbid Obesity Surgery. The European
Institute of Tele-Surgery. IRCAD-EITS. University
of Strasbourg.
Strasbourg, Alsace, France. October 1st, 2005.
Chemounay J, Belsley SF, Cordova AC, Wasielewski A, BALLANTYNE GH.
Does age impact % Excess Weight Loss (% EWL) after Laparoscopic
Rouxe-en-Y Gastric Bypass (LRYGB)? Society of American Gastrointestinal
Endoscopic Surgeons (SAGES).Dallas,
Texas. April 27th, 2006
(Poster).
Falloon M, Belsley SJ, Farkas D, Wasielewski A, BALLANTYNE GH. Does
C Reactive Protein (CRP) decrease proportionately with body mass index (BMI)
after both Lap Band & LRYGB? Society of American Gastrointestinal Endoscopic
Surgeons (SAGES).
Dallas, Texas. April 27th, 2006
(Poster).
BALLANTYNE GH. The Future of
Bariatric Surgery. Advanced Course in Morbid Obesity Surgery. The European
Institute of Tele-Surgery. IRCAD-EITS. University
of Strasbourg.
Strasbourg, Alsace, France. June 1st, 2006.
BALLANTYNE GH. Introduction to neuroendocrine
bariatric surgery. Metabolic Symposium for Morbid Obesity. International
Federation for the Study of Obesity (IFSO). Sydney, Australia. August 29th, 2006.
BALLANTYNE GH. Metabolic impact after
bariatric surgery in patients with Type 2 Diabetes Mellitus. At: Incretins: New
Visions for Old Hormones. Brazilian Diabetes Society & the Brazilian
Association for the Study of Obesity. University
of Campinas, Sao Paulo, Brazil. November 18th, 2006.
Peptide YY(1-36) and peptide YY(3-36): Part II. Changes
after gastrointestinal surgery and bariatric surgery.
Obes Surg. 2006 Jun;16(6):795-803. Review.
PMID: 16756746 [PubMed - indexed for MEDLINE]
Changes in insulin resistance following bariatric surgery
and the adipoinsular axis: role of the adipocytokines, leptin, adiponectin
and resistin.
Obes Surg. 2005 May;15(5):692-9. Review.
PMID: 15946462 [PubMed - indexed for MEDLINE]
Changes in insulin resistance following bariatric surgery:
role of caloric restriction and weight loss.
Obes Surg. 2005 Apr;15(4):462-73. Review.
PMID: 15946423 [PubMed - indexed for MEDLINE]
The learning curve measured by operating times for
laparoscopic and open gastric bypass: roles of surgeon's experience,
institutional experience, body mass index and fellowship training.
Obes Surg. 2005 Feb;15(2):172-82.
PMID: 15810124 [PubMed - indexed for MEDLINE]
Predictors of prolonged hospital stay following open and
laparoscopic gastric bypass for morbid obesity: body mass index, length of
surgery, sleep apnea, asthma, and the metabolic syndrome.
Obes Surg. 2004 Sep;14(8):1042-50.
PMID: 15487110 [PubMed - indexed for MEDLINE]
Measuring outcomes following bariatric surgery: weight loss
parameters, improvement in co-morbid conditions, change in quality of life
and patient satisfaction.
Obes Surg. 2003 Dec;13(6):954-64. Review.
PMID: 14738691 [PubMed - indexed for MEDLINE]
Short-term results of laparoscopic gastric bypass in
patients with BMI > or = 60.
Obes Surg. 2002 Oct;12(5):643-7.
PMID: 12448385 [PubMed - indexed for MEDLINE]
